Galena Biopharma Inc. Will Pay Over $7.55 Million to Settle False Claims Allegations Relating to Opioid Drug

On September 8, 2017, Galena Biopharma Inc. settled with the DOJ for more than $7.55 million for paying kickbacks to doctors encouraging them to prescribe the fentanyl-based drug Abstral, in violation of the False Claims Act (“FCA”).  The government claims, among other infractions, that Galena provided more than 85 free meals to physicians and medical staff from one particular, high-prescribing practice; gave doctors and speakers $5,000 and $6,000, respectively, plus expenses, to participate in an ... Continue Reading

Individuals Charged with Securities and Wire Fraud

On September 6, 2017, Craig Carton and Michael Wright were arrested and charged with securities fraud, wire fraud and conspiracy.  According to DOJ, Carton and Wright, along with a third individual, induced investors, including a hedge fund, to provide them with funds that would be used to purchase and re-sell concert tickets on the secondary market.  The three individuals allegedly misrepresented to investors that they had access to blocks of concert tickets through a relationship ... Continue Reading

Novo Nordisk Will Pay $58 Million for Non-compliance with FDA-Mandated Risk Program

On September 5, 2017, Novo Nordisk Inc., a pharmaceutical manufacturer and subsidiary of Novo Nordisk U.S. Holdings Inc., itself a subsidiary of Danish Novo Nordisk A/S, agreed to pay $58.65 to settle claims it did not comply with the FDA-mandated Risk Evaluation and Mitigation Strategy (REMS) for the Type II diabetes drug Victoza.  The payment includes $12.15 million in disgorgement for Federal Food, Drug, and Cosmetic Act (“FDCA”) violations, as well as a $46.5 million ... Continue Reading

Santa Fe-Based Christus St. Vincent Regional Medical Center and Partner Pay $12.24 Million to Resolve Medicaid False Claims Act Allegations

On September 1, 2017, Christus St. Vincent Regional Medical Center, along with its partner Christus Health (“Christus”), agreed to pay $12.24 million for violations of the False Claims Act (“FCA”) to settle DOJ charges that they made illegal donations to local county governments which then funded the state share of Medicaid payments to the hospital.  Santa Fe’s now-defunct Sole Community Provider (“SCP”) Program provided supplemental Medicaid funds to hospitals in underserved communities, and the federal ... Continue Reading

Former Investment Advisor Arrested for $20 Million Fraud

On August 24th, Daryl Gene Bank, the former owner of an Investment Company in Virginia Beach, was arrested and, along with his co-conspirator Raeann Gibson, charged with conspiracy to commit mail and wire fraud, and engaging in unlawful monetary transactions.  Bank and Gibson allegedly entered into a conspiracy to operate multiple fraud schemes between January 2012 and July 2017.  The co-conspirators prepared materially false and misleading investment offerings, and knowingly omitted material information, to at ... Continue Reading

Two International Bank Managers Charged in Libor Interest Rate Manipulation Scheme

On August 24, 2017, Danielle Sindzingre and Muriel Bescond, both French bank managers, were indicted and charged with one count of conspiring to transmit false reports concerning market information that tends to affect a commodity, as well as four counts of transmitting these false reports.  The two French bank managers allegedly transmitted false and misleading information in connection with the London Interbank Offer Rate (LIBOR), a benchmark interest rate that is calculated for various currencies ... Continue Reading

E-Commerce Company and Top Executive Agree to Plead Guilty to Price-Fixing Conspiracy for Customized Promotional Products / Second E-Commerce Company and its Top Executive Agree to Plead Guilty to Price-Fixing Conspiracy in Customized Promotional Products Industry

Two e-commerce companies and their top executives pled guilty to conspiring to fix prices for customized promotional products sold online to U.S. customers.  On August 7, 2017, Zaappaaz Inc. (d/b/a WB Promotions Inc.,, and pled guilty to conspiring to price fix, and its President Azim Makanojiya, pled guilty to criminally violating the Sherman Act.  According to the charges, conspirators used social media and encrypted messages to engage in illegal agreements to fix the ... Continue Reading

Former ArthroCare Corporation CEO Convicted for Role in $750 Million Securities Fraud

On August 18, 2017, a federal jury found former CEO of ArthroCare Michael Baker guilty of one count of conspiracy to commit wire fraud and securities fraud, seven counts of wire fraud, two counts of securities fraud and two counts of making false statements.  Baker and his co-conspirators were alleged to have artificially inflated sales and revenue by determining which of their products would meet Wall Street needs, based on analysts’ forecasts, and then “parked” ... Continue Reading

Mylan Pays $465 Million to Resolve False Claims Act Investigation for Underpaying EpiPen Rebates

On August 17, 2017, Mylan Inc. and Mylan Specialty L.P. resolved claims brought under the whistleblower provisions of the False Claims Act (“FCA”), agreeing to pay $465 million in a civil settlement with government regulators.  The government alleged that Mylan erroneously and knowingly reported EpiPen to Medicaid as a generic medication, despite the unavailability of any equivalent pharmaceutical, allowing them to charge high prices on the private market while evading corresponding obligations to Medicaid under ... Continue Reading

Five Individuals Charged with Participating in Three Insider Trading Schemes Generating More Than $5 Million in Profits on Inside Information Misappropriated from an Investment Bank

On August 16, 2017, five individuals were arrested and charged for their roles in overlapping insider trading schemes.    Michael Siva, Roberto Rodriguez, Rodolfo Sablon, Jhonatan Zoquier, and Jeffrey Rogiers were each charged with conspiracy, wire fraud, and multiple counts of securities fraud and fraud in connection with a tender offer.  The U.S. Attorney’s Office also announced the unsealing of guilty pleas from August 9, 2017 by Daniel Rivas and James Moodhe, who admitted to engaging ... Continue Reading

Acting Manhattan U.S. Attorney Announces Agreement with Swiss Asset Management Firm to Resolve Criminal Tax Investigation

On August 15, 2017, Prime Partners SA entered into a non-prosecution agreement with the U.S. Attorney’s Office for the Southern District of New York.  As part of that agreement, Prime Partners agreed to pay $5 million to the U.S.  Prime Partners admitted that it aided its clients in concealing their ownership of foreign bank accounts in order to avoid paying taxes—totaling about $680,000—to the U.S. government.  As part of this effort, Prime Partners created sham ... Continue Reading

Investment Bank Vice President Pleads Guilty to Insider Trading

On August 10, 2017, Avaneesh Krishnamoorthy pled guilty to engaging in a scheme to commit insider trading.  Krishnamoorthy was the vice president and risk management specialist for a New York-based investment bank.  Through his position, he learned material nonpublic information concerning the acquisition of a company, whose shares are traded on the New York Stock Exchange, by a private equity fund.  He subsequently used this information and traded in the stock options of the company ... Continue Reading

Former Broker Sentenced to 15 Months Imprisonment for $131 Million Market Manipulation Scheme

In July and August, several individuals were sentenced for their involvement in a $131 million securities fraud scheme. From 2009 to 2015, the coconspirators fraudulently controlled the price and volume of shares traded in a publicly traded company called ForceField Energy Inc. by using nominees to buy and sell company stock without disclosing this to other investors, orchestrating ForceField stock trading that would appear as real trading volume and interest, and hiding payments to stock ... Continue Reading

Former Cocoa Company Executives Arrested for Defrauding Lenders of $400 Million

On August 8, 2017, a federal court in New York unsealed the indictment charging Peter G. Johnson, Peter B. Johnson, and Thomas Reich with defrauding banks by using false “borrowing base” reports that were designed to secure a $400 million line of credit for their company.  As part of this fraud, the defendants allegedly lied repeatedly about the financial condition of the company and, through “borrowing base” reports required by the banks, deceived lenders about ... Continue Reading

Martin Shkreli, Former Hedge Fund Manager, Convicted in Multi-Million Dollar Fraud Scheme

On August 4, 2017, Martin Shkreli was convicted by jury of three counts charging him with securities fraud and securities fraud conspiracy.  The conviction related to Shreli’s role as the founder and managing member of two hedge funds, MSMB Capital Management LP and MSMB Healthcare Management LP, and as the former CEO of the biopharmaceutical company, Retrophin Inc.  The trial, which lasted six weeks before United States District Court Judge Kiyo A. Matsumoto, convicted Shkreli ... Continue Reading